Dyadic prices public offering of 6.05 million shares

Dyadic International Inc. (NASDAQ: DYAI) announced the pricing of its underwritten public offering of 6,052,000 shares of common stock. The biotechnology company expects the offering to close on August 1, 2025, subject to customary closing conditions.

Craig-Hallum Capital Group LLC serves as the sole managing underwriter for the offering. The company did not disclose the pricing details in the announcement.

Dyadic plans to use net proceeds from the offering for working capital and general corporate purposes, including product development, sales and marketing activities. The Jupiter, Florida-based company focuses on producing proteins for life sciences, food and nutrition, and industrial biotechnology applications using proprietary gene expression platforms.

The securities are being offered under an effective shelf registration statement on Form S-3 filed with the Securities and Exchange Commission on August 9, 2023, and declared effective on August 25, 2023. A preliminary prospectus supplement and accompanying prospectus relating to the offering was filed with the SEC.

The company operates proprietary microbial platforms including C1 and Dapibus expression systems to produce recombinant proteins that are sold or licensed to partners across various markets.

You May Also Be Interested In

• DEFSEC Technologies (DFSC) files for 4.05M share offering by selling stockholders
• Eco Wave Power signs deal with AI engineering GmbH on digital twin platform
• Shell completes $16.5B acquisition of ARC Resources